Susquehanna International Group’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$130K	Sell	10,567 -41	-0.4%	-$503	﹤0.01%	5784
2025 Q1	$117K	Buy	+10,608	New	+$117K	﹤0.01%	5805